Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
NCT ID: NCT01293552
Last Updated: 2013-07-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
72 participants
INTERVENTIONAL
2011-01-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of the Use of Botox on Acne
NCT00765375
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
NCT01391299
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
NCT02116361
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002
Trial of OnabotulinumtoxinA for Depression in Parkinson Disease
NCT03069911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
blank vehicle formulation
Vehicle
Dose 1
Dose 1
ANT-1207
single dose application
Dose 2
Dose 2
ANT-1207
single dose application
Dose 3
Dose 3
ANT-1207
single dose application
Dose 4
Dose 4
ANT-1207
single dose application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANT-1207
single dose application
Vehicle
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 15 to 40 papules and pustules, and 5 to 50 open and/or closed comedones
* no presence of nodules
* female subjects must be not pregnant and non-lactating
Exclusion Criteria
* use of topical steroids on the face 4 weeks prior and during the study
* use of systemic corticosteroids 6 weeks prior and during the study
* topical or systemic acne treatment in the 4 weeks prior to Baseline
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anterios Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Total Skin & Beauty Dermatology Center
Birmingham, Alabama, United States
International Dermatology Research
Miami, Florida, United States
Palm Beach Esthetic Dermatology and Laser Center
West Palm Beach, Florida, United States
Gwinnett Clinical Research Center Inc.
Snellville, Georgia, United States
Dermatology Specialists Research, LLC
Louisville, Kentucky, United States
William Coleman III, MD, APMC
Metairie, Louisiana, United States
Grekin Skin Institute
Warren, Michigan, United States
The Dermatology Group, P.C.
Verona, New Jersey, United States
Gramercy Park Dermatology
New York, New York, United States
Skin Search of Rochester, Inc
Rochester, New York, United States
Dermatology Consulting Services
High Point, North Carolina, United States
Penn State Hershey Medical Center Department of Dermatology
Hershey, Pennsylvania, United States
Yardley Dermatology Associates
Yardley, Pennsylvania, United States
The Skin Wellness Center
Knoxville, Tennessee, United States
DermResearch, Inc.
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANT-1207-101-ACNE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.